Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company’s ...

Alpha Cognition Inc. (ACOG) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, ACOG's 50-day simple moving average crossed ...

99% of patients were eligible for aspirin, per ACOG guidelines. Prescribing rates increased 81% after the intervention. Universal low-dose aspirin may particularly benefit lower-income urban ...